Hemophilia Foundation recommends prophylactic use of clotting factors.
Skolnick
A A
AA
D001779:Blood Coagulation Factors / Q000191:economics / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D005164:Factor IX / Q000191:economics / Q000627:therapeutic use; D005169:Factor VIII / Q000191:economics / Q000627:therapeutic use; D006467:Hemophilia A / Q000517:prevention & control*; D006801:Humans; D007223:Infant
D001779:Blood Coagulation Factors; D005169:Factor VIII; D005164:Factor IX